Steensgaard, Dorte Bjerre
Novo Nordisk (Denmark)
3 papers on CoChatORCID 0000-0001-8607-0576
Most cited papers
- Verified
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry
Diabetes Treatment and ManagementChemical Synthesis and Analysis
Cited by 1,105
- Verified
Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
Jonassen, I., Havelund, S., Hoeg-Jensen, T., Steensgaard, D. B., Wahlund, P.-O., & Ribel, U. (2012) · Pharmaceutical Research
Protein purification and stabilityDiabetes Management and Research
Cited by 448
- Verified
Ligand-Controlled Assembly of Hexamers, Dihexamers, and Linear Multihexamer Structures by the Engineered Acylated Insulin Degludec
Steensgaard, D. B., Schluckebier, G., Strauss, H. M., Norrman, M., Thomsen, J. K., Friderichsen, A. V., Havelund, S., & Jonassen, I. (2013) · Biochemistry
Protein purification and stabilityProtein Structure and Dynamics
Cited by 86
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free